|
Multiple sclerosis
Citations 451-460 of 469 total displayed.
|
Past content
(since Jan 2001):
|
- ARTICLES
Liver and thyroid function and autoimmunity during interferon-ß1b treatment for MS
- L. Durelli, B. Ferrero, A. Oggero, E. Verdun, A. Ghezzi, E. Montanari, and M. Zaffaroni
Neurology 2001; 57: 1363-1370.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Distinct chemokine receptor and cytokine expression profile in secondary progressive MS
- Torben L. Sørensen and Finn Sellebjerg
Neurology 2001; 57: 1371-1376.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS
- R. Zivadinov, R. A. Rudick, R. De Masi, D. Nasuelli, M. Ukmar, R. S. Pozzi–Mucelli, A. Grop, G. Cazzato, and M. Zorzon
Neurology 2001; 57: 1239-1247.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Axonal loss in normal-appearing white matter in a patient with acute MS
- C. Bjartmar, R. P. Kinkel, G. Kidd, R. A. Rudick, and B. D. Trapp
Neurology 2001; 57: 1248-1252.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Optimizing the association between disability and biological markers in MS
- N. F. Kalkers, E. Bergers, J. A. Castelijns, M. A. A. van Walderveen, J. C. J. Bot, H. J. Adèr, C. H. Polman, and F. Barkhof
Neurology 2001; 57: 1253-1258.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Association of a tumor necrosis factor  polymorphism with MS susceptibility
- Brian G. Weinshenker, David D. Hebrink, Elizabeth Atkinson, and Orhun H. Kantarci
Neurology 2001; 57: 1341-1342.
[Full text]
[PDF]
- ARTICLES
Serum IFN neutralizing antibodies and neopterin levels in a cross-section of MS patients
- S. D. Cook, J. R. Quinless, A. Jotkowitz, and P. Beaton
Neurology 2001; 57: 1080-1084.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Satellite potentials on EMG: Neurophysiologic evidence of axonal transection in MS?
- G. Antonini, S. Morino, F. Giubilei, A. Paolillo, V. Ceschin, F. Gragnani, E. Bucci, and C. Pozzilli
Neurology 2001; 57: 1126-1128.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
TNF production by CD4+ T cells predicts long-term increase in lesion load on MRI in MS
- J. Killestein, N. F. Kalkers, J. F. Meilof, F. Barkhof, R. A. W. van Lier, and C. H. Polman
Neurology 2001; 57: 1129-1131.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Downregulation of transforming growth factor-ß1 in interferon-ß1a-treated MS patients
- J. D. Lünemann, O. Aktas, P. Gniadek, R. Zschenderlein, and F. Zipp
Neurology 2001; 57: 1132-1134.
[Abstract]
[Full text]
[PDF]
|
|
